ASP Isotopes Announces $50 Million Financing in Merger to Nasdaq-List Helium Platform
ASPI•ASP Isotopes’ Noble Africa LLC will merge with an ENDRA subsidiary to form Nasdaq-listed Noble Africa Inc., with ASP owning roughly 89% post-close. A $50 million private placement, including $20 million from ASP and $30 million from others, will fund development phases of the Virginia Gas Project.
1. Proposed Merger Structure
ASP Isotopes’ subsidiary, Noble Africa LLC, will merge with a subsidiary of ENDRA Life Sciences to form Noble Africa Inc., a Nasdaq-listed company. The combined entity will trade under ticker NOBA upon closing in the third or fourth quarter of 2026, pending regulatory and shareholder approvals.
2. Private Placement Financing
Noble Africa has secured commitments for a $50 million private placement, led by a $20 million investment from ASP Isotopes and $30 million from accredited investors. The financing includes $750,000 from ASP’s directors and management and will close immediately before the merger completion.
3. Ownership and Governance
Post-closing, ASP Isotopes is expected to own approximately 89% of Noble Africa Inc., pre-closing ENDRA stockholders about 3%, and new investors 7%. The board will comprise six directors designated by ASP, one by ENDRA, with Paul E. Mann as CEO and Nick Mitchell as COO.
4. Strategic Rationale and Project Development
The merger aims to create one of the few publicly traded helium development platforms, providing direct investor exposure to the Virginia Gas Project in South Africa. Proceeds will support Phase 1 and Phase 2 development to address tightening helium supply for critical industries.
